The Lipid Panel Test Market is estimated at US$11.6 billion in 2026 and is projected to grow at a CAGR of 9.1% to reach US$23.3 billion by 2034.
Relevant uses and settings include clinical laboratories, hospital diagnostics, preventive health screening, physician offices, wellness programs, and home sample collection support. Commercial considerations include reimbursement variability, testing commoditization, patient compliance gaps, and competition between centralized laboratories and point of care testing models.
This product will be delivered within 1-3 business days.
Market Overview
The Lipid Panel Test Market covers diagnostic testing services and consumables used to measure cholesterol and related lipids for cardiovascular risk assessment and routine health monitoring.Relevant uses and settings include clinical laboratories, hospital diagnostics, preventive health screening, physician offices, wellness programs, and home sample collection support. Commercial considerations include reimbursement variability, testing commoditization, patient compliance gaps, and competition between centralized laboratories and point of care testing models.
Key Companies Analysed
- Quest Diagnostics
- Labcorp
- Abbott
- Roche
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Randox Laboratories
- Sekisui Diagnostics
- Trinity Biotech
- DiaSys Diagnostic Systems
- HORIBA
- Mindray
- Sysmex
- Acon Laboratories
- Ortho Clinical Diagnostics
- Beckman Coulter
- EKF Diagnostics
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Lipid Panel Test Market Overview
3. Lipid Panel Test Market Dynamics
4. Lipid Panel Test Market Strategic Analysis
5. Global Lipid Panel Test Market Size, Share and Forecast, 2025-2034
6. North America Lipid Panel Test Market Outlook to 2034
7. Europe Lipid Panel Test Market Outlook to 2034
8. Asia-Pacific Lipid Panel Test Market Outlook to 2034
9. Middle East and Africa Lipid Panel Test Market Outlook to 2034
10. South and Central America Lipid Panel Test Market Outlook to 2034
11. Lipid Panel Test Market Competitive Landscape
12. Appendix
Companies Mentioned
- Quest Diagnostics
- Labcorp
- Abbott
- Roche
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Randox Laboratories
- Sekisui Diagnostics
- Trinity Biotech
- DiaSys Diagnostic Systems
- HORIBA
- Mindray
- Sysmex
- Acon Laboratories
- Ortho Clinical Diagnostics
- Beckman Coulter
- EKF Diagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 11.6 Billion |
| Forecasted Market Value ( USD | $ 23.3 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
